CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash	$ 25,977	$ 35,894
Prepaid expenses	10,680	14,685
Total current assets	36,657	50,579
Investments held in Trust Account	1,190,366	1,179,991
Total Assets	1,227,023	1,230,570
Current liabilities:
Promissory notes	1,970,000	1,970,000
Extension loan - related party	190,000	190,000
Working Capital Loan- related party	1,474,003	1,314,003
Accounts payable and accrued expenses	166,971	206,954
Total current liabilities	3,800,974	3,680,957
Deferred underwriters' discount	2,415,000	2,415,000
Total Liabilities	6,215,974	6,095,957
Commitments and Contingencies
Ordinary shares subject to possible redemption, 93,484 shares at redemption value of $12.733 and $12.622 per share as of March 31, 2026 and December 31, 2025, respectively	1,190,366	1,179,991
Shareholders' Deficit:
Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 2,310,750 shares issued and outstanding as of March 31, 2026 and December 31, 2025 (excluding 93,484 shares subject to possible redemption)	231	231
Additional paid-in capital	0	0
Accumulated deficit	(6,179,548)	(6,045,609)
Total Shareholders' Deficit	(6,179,317)	(6,045,378)
Total Liabilities, Temporary Equity, and Shareholders' Deficit	$ 1,227,023	$ 1,230,570